Special Report: Creso Pharma (ASX:CPH) says if the down-scheduling of cannabidiol goes ahead in December it would unlock a major … Read More
The post Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.